NCT00834522View on ClinicalTrials.gov

Granisetron 1 mg Tablets, Non-fasting

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Healthy
Interventions
DRUG

Granisetron hydrochloride 1 mg tablets

2 x 1 mg, single dose non-fasting

DRUG

Kytril® 1 mg tablets

2 x 1 mg, single dose non-fasting

Trial Locations (1)

M1R 5A3

Pharma Medica Research Inc, Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00834522 - Granisetron 1 mg Tablets, Non-fasting | Biotech Hunter | Biotech Hunter